Cargando…

TEIPP peptides: exploration of unTAPped cancer antigens

The intracellular peptide pump TAP feeds antigenic peptides for loading onto HLA class I molecules, and its down-modulation is a frequent immune evasion mechanism in human cancers. Two recent papers describe which ‘hidden‘ antigens we might exploit to target these escaped cancer variants by CD8 T ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marijt, Koen A., Van Der Burg, Sjoerd H., van Hall, Thorbald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Author’s View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682355/ https://www.ncbi.nlm.nih.gov/pubmed/31413908 http://dx.doi.org/10.1080/2162402X.2019.1599639

Ejemplares similares

Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement
por: Marijt, Koen A., et al.
Publicado: (2021)

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
por: Doorduijn, Elien M., et al.
Publicado: (2017)

Refusing to TAP out: 16 new human TEIPPs identified
por: Gigoux, Mathieu, et al.
Publicado: (2018)

Identification of non-mutated neoantigens presented by TAP-deficient tumors
por: Marijt, Koen A., et al.
Publicado: (2018)

PD-L1 immune suppression in cancer: Tumor cells or host cells?
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
por: Garrido, Greta, et al.
Publicado: (2019)

Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling
por: Marijt, Koen A., et al.
Publicado: (2019)

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
por: van Luijn, Marvin M., et al.
Publicado: (2012)

T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1(b) with TAP-Independent Peptides Are Semi-Invariant Lymphocytes
por: Doorduijn, Elien M., et al.
Publicado: (2018)

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
por: Aruga, Atsushi
Publicado: (2013)

Long peptide-based cancer immunotherapy targeting tumor antigen-specific CD4(+) and CD8(+) T cells
por: Tomita, Yusuke, et al.
Publicado: (2013)

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

A self antigen reopens the games in pancreatic cancer
por: Cappello, Paola, et al.
Publicado: (2013)

Personalized peptide vaccination for advanced colorectal cancer
por: Sasada, Tetsuro, et al.
Publicado: (2015)

Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs
por: Yi, Yongxiang, et al.
Publicado: (2012)

Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
por: Walker, Paul R., et al.
Publicado: (2015)

Approaching untargetable tumor-associated antigens with antibodies
por: Dao, Tao, et al.
Publicado: (2013)

Detection of cancer/testis antigens as a diagnostic tool in routine pathology practice
por: Chen, Yao-Tseng
Publicado: (2014)

Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens
por: Scanlon, Christina Springstead, et al.
Publicado: (2013)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012)

Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells
por: Larmonier, Nicolas, et al.
Publicado: (2012)

HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens
por: Xu, Qing-Wen, et al.
Publicado: (2013)

Future Challenges in Cancer Resistance to Immunotherapy
por: van Elsas, Marit J., et al.
Publicado: (2020)

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)

Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond
por: Urbanska, Katarzyna, et al.
Publicado: (2012)

Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2014)

Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard
por: Hailemichael, Yared, et al.
Publicado: (2013)

A glypican-3-derived peptide vaccine against hepatocellular carcinoma
por: Sawada, Yu, et al.
Publicado: (2012)

Lessons learned from a highly-active CD22-specific chimeric antigen receptor
por: Long, Adrienne H., et al.
Publicado: (2013)

High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies
por: Binder, David C, et al.
Publicado: (2013)

A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen
por: Rosental, Benyamin, et al.
Publicado: (2012)

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging
por: Aarntzen, Erik H.J.G., et al.
Publicado: (2012)

CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014)

High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them
por: Wilde, Susanne, et al.
Publicado: (2012)

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies
por: Omokoko, Tana, et al.
Publicado: (2015)

In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids
por: Galili, Uri
Publicado: (2013)

Location, location, location: The relationship of anatomic site, antigen expression, and T-cell infiltration in human melanoma metastases
por: Bartlett, Edmund K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g1pelsgq1og66bme6g4mcshtsj